Zaleplon and driving impairment

Journal of Forensic Sciences

Volumn 48, Issue 3, 2003, Pages 677-679

  Stillwell, Matthew E ^a  

^a Toxicology Unit   (United States)

Author keywords

Driving; Forensic science; Impairment; Sonata

Indexed keywords

ZALEPLON;

ADULT; ARTICLE; BALANCE DISORDER; CASE REPORT; CENTRAL NERVOUS SYSTEM DEPRESSION; CONSCIOUSNESS DISORDER; DRIVING ABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; ELUTION; HUMAN; MALE; MOTOR DYSFUNCTION; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; SYMPTOM; TRAFFIC ACCIDENT;

EID: 0038710971     PISSN: 00221198     EISSN: None     Source Type: Journal    
DOI: 10.1520/jfs2002357     Document Type: Article

References (13)

1. Anderson WH, Fuller DC. A simplified procedure for the isolation, characterization, and identification of weak acid and neutral drugs from whole blood. J Anal Toxicol 1987;198-205.
2. Physicians' Desk Reference. 56th edition, 2002. Medical Economics Company, Montvale, NJ.
3. Baselt RC. Drug effects on psychomotor performance. Biomedical Publications, Foster City, CA.
4. Allen D, Curran HV, Lader M. The effects of single doses of CL284,846, lorazepam, and placebo on psychomotor and memory function in normal male volunteers. Eur J Clin Pharm 1993;45:313-20.
5. Troy SM, Lucki I, Unruh MA, et al. Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance. J Clin Psychopharm 2000;20:328-37.
6. Vermeeren A, Danjou PE, O'hanlon JF. Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance. Hum Psychopharm Clin Exp 1998;13(S2):S98-S108.
7. Rosen AS, Fournie P, Darwish M, Danjou P, Troy S. Zaleplon pharmacokinetics and absolute bioavailability. Biopharm Drug Disp 1999;20:171-5.
8. Foerester EH, Hatchett D, Garriott JC. A rapid, comprehensive screening procedure for basic drugs in blood or tissues by gas chromatography. J Anal Toxicol 1978;50-5.
9. Beer B, Ieni JR, Wu WH, Clody D, Amorusi P, Rose J, et al. A placebo-controlled evaluation of single, escalating doses of CL 284,846, a nonbenzodiazepine hypnotic. J Clin Pharmacol 1994;34:335-44.
10. Danjou P, Paty I, Fruncillo R, Worthington P, Unruh M, Cevallos W, et al. A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening. J Clin Pharmacol 1999;48:367-74.
11. th ed. Goodman A, Gilman LD, editors. 1985 Macmillan Publishing Company, New York, NY 1985:339-71.
12. Baselt RC, Cravey RH. Disposition of toxic drugs and chemicals in man. 5th ed. Foster City: Chemical Toxicology Institute 2000:170-2.
13. Moffat AC, Jackson JV, Moss MS, Widdop B. Clarke's isolation and identification of drugs. London, UK: The Pharmaceutical Press 1986;457.